JSM 2004 - Toronto

JSM Activity #338

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
Legend: = Applied Session, = Theme Session, = Presenter
FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center
Add To My Program
338 Wed, 8/11/04, 10:30 AM - 12:20 PM TCC-714 B
Sample Size Determination and Power - Contributed - Papers
Biopharmaceutical Section
Chair(s): Viswanath Devanarayan, Eli Lilly and Company
     10:35 AM   Toward a New Way of Thinking about Power and Sample Size — John Johnson, Rho, Inc
     10:50 AM   Uncertainty in Planning Sample Size of Phase III Trial Based on Phase II Data — Sue-Jane Wang, U.S. Food and Drug Administration; H.M. James Hung, U.S. Food and Drug Administration
     11:05 AM   Statistical Power and Sample Size Determination for Clinical Trials with Multiple Primary Endpoints — Chengjie Xiong, Washington University, St. Louis; J. Philip Miller, Washington University, St. Louis
     11:20 AM   Can Larger Sample Size Provide More Power? — Mingxiu Hu, Pfizer Global Research & Development; Gordon Lan, Aventis Pharmaceuticals; Rebecca J. Benner, Pfizer Inc.
     11:35 AM   Setting Tolerance Limits in Clinical Trials with Dichotomous Outcomes — Boris G. Zaslavsky, U.S. Food and Drug Administration
     11:50 AM   Simulation Studies of the Effects of Sample Size, and Stratification Factors on Performance of the Fisher's Exact and Cochran-Mantel-Haenszel Tests — David Carlin, MedImmune, Inc.; Harry Yang, MedImmune, Inc.
     12:05 PM   Floor Discussion
 

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004